← Back to headlines
Nemera Owners Explore Strategic Sale Amid Surging Demand for GLP-1 Injection Devices
The parent company of medical device manufacturer Nemera is considering selling the firm as global demand for weight-loss drug delivery systems continues to accelerate, boosting valuation prospects.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
